<?xml version="1.0" encoding="UTF-8"?>
<p id="p0255">In the global medicinal plant value chain, certification and safety requirements are critical. This limits the power and influence of disorganised sellers/collectors/producers and actual participation of producer organizations in partnerships. Though partnerships are associated with some constraints, they have the potential to shorten the supply chain, improve quality and earning of premiums by farmers, as well as trigger the development of human capital associated with development of certification schemes [
 <xref rid="bib78" ref-type="bibr">75</xref>]. The role of organisations in market access for plant derived medicines is thus critical [
 <xref rid="bib54" ref-type="bibr">52</xref>]. For example, intersectoral partnerships can improve the position of small scale producersâ€™ organisations and stimulate adoption of certification standards that increase their visibility, market access and realisation of premium prices. In the long run, value chain partnerships increase the potential for improved environmental management [
 <xref rid="bib78" ref-type="bibr">75</xref>].
</p>
